[Pleural empyema and Tauroflex. Study of a new bactericidal agent].
A pilot study of 8 cases of lung empyema treated with taurolin, a new bactericidal agent, is reported. Rapid sterilization of exudates and favorable clinical course are discussed. Thanks to the absence of toxicity and its bacteriological efficacy, taurolin is a useful therapeutic agent in pleural empyema. Its use in the prophylaxis of complications in thoracic surgery is suggested.
D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D004341:Drug Evaluation; D004653:Empyema / Q000188:drug therapy* / Q000382:microbiology; D004926:Escherichia coli / Q000302:isolation & purification; D005557:Formaldehyde / Q000627:therapeutic use*; D006193:Haemophilus influenzae / Q000302:isolation & purification; D006801:Humans; D013210:Staphylococcus / Q000302:isolation & purification; D013829:Thiadiazines / Q000627:therapeutic use*; D013843:Thiazines / Q000627:therapeutic use*
D000891:Anti-Infective Agents, Local; D013829:Thiadiazines; D013843:Thiazines; D005557:Formaldehyde
Empyèmes pleuraux et Tauroflex. Etude d'un nouveau bactéricide.